Abstract
Objective: To compare health-related quality of life (HR-QoL) among rural Chinese patients with upper gastrointestinal (GI) diseases across different pathological stages and identify influencing factors.
Methods: A cross-sectional survey of 406 patients in Shandong province used EORTC QLQ-C30, QLQ-OES18, and QLQ-STO22 questionnaires. Analysis included MANOVA, Kruskal–Wallis tests, and multivariate regression.
Results: Significant HR-QoL declines were observed in advanced stages compared to precancerous and early stages. Key factors included residence, age, education, and pathological stage.
Conclusions: Advanced upper GI cancer care must prioritize symptom management and tailored support based on patient demographics.
Introduction
Upper gastrointestinal cancers, particularly esophageal and gastric, remain leading causes of mortality in China. While clinical outcomes like survival rates have improved, the subjective experience of the patient—Health-Related Quality of Life (HR-QoL)—is often overlooked. This study focuses on rural populations, who face unique socioeconomic hurdles and limited healthcare access, to understand how well-being shifts across the pathological spectrum of GI disease.
Methods and Study Population
The researchers conducted a cross-sectional survey between July and September 2018 in Feicheng and Linqu counties, Shandong Province. These areas are known for high GI disease prevalence. A total of 406 patients were recruited and categorized into precancerous, early-stage, and advanced-stage groups.
HR-QoL was assessed using validated European Organization for Research and Treatment of Cancer (EORTC) instruments: the core QLQ-C30 for general symptoms, and the site-specific QLQ-OES18 (esophageal) and QLQ-STO22 (gastric) modules.
Key Results
The study identified a significant "quality of life cliff" as patients transitioned to advanced stages. While there were minimal differences in HR-QoL between precancerous and early-stage groups, advanced-stage patients experienced sharp declines in physical, social, and emotional functioning.
The Impact of Disease Stage
Global QoL scores dropped significantly in the advanced group (56.25 for esophageal; 61.67 for gastric) compared to earlier stages (~70-79). Symptom severity, including fatigue, pain, and appetite loss, increased dramatically in advanced stages (p < 0.0001). For esophageal patients, reflux and swallowing difficulties were particularly debilitating, while gastric patients faced increasing anxiety as the disease progressed.
Socioeconomic Influences
Multivariate regression revealed that education level and residence area were critical predictors of HR-QoL. Higher education correlated with better outcomes, likely due to improved health literacy and coping mechanisms. Furthermore, the high scores for "financial difficulties" across all groups—particularly for esophageal patients—highlight the significant economic burden of long-term GI disease care in rural China.
Conclusion
The findings underscore the necessity of integrating palliative care and symptom management into standard oncological workflows, particularly for advanced-stage patients. Tailored care models that address the specific psychological and financial needs of rural populations—accounting for age and education—are essential to improving the overall well-being of patients with upper GI diseases.
Summary updated